United States 115th Congress ✓ Enacted · P.L. 115-80 1 D cosponsors

S 920 — National Clinical Care Commission Act

Last action — Became Public Law No: 115-80.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced April 24, 2017. Enacted.

Prognosis

Advancing 52% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 D).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.

Bill Text

What changed in the latest version

51 added · 55 removed

Plain-language change summary

The amendment adds language specifying that the National Clinical Care Commission will include twelve additional voting members with expertise in the prevention, care, and epidemiology of relevant diseases and complications. This change clarifies the composition of the Commission and ensures a broad range of expertise is represented. The amendment highlights the importance of including diverse perspectives in addressing the disease burden in the United States.

→
Previous
Latest
[Congressional Bills 115th Congress] [From the U.S.
[115th Congress Public Law 80] [From the U.S.
Government Publishing Office] [S.
Government Publishing Office] [[Page 131 STAT.
920 Engrossed in Senate (ES)] <DOC> 115th CONGRESS 1st Session S.
1261]] Public Law 115-80 115th Congress An Act To establish a National Clinical Care Commission.
920 _______________________________________________________________________ AN ACT To establish a National Clinical Care Commission.
<<NOTE:
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1.
Nov.
2, - [S.
920]>> Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, <<NOTE:
National Clinical Care Commission Act.>> SECTION 1.
NATIONAL CLINICAL CARE COMMISSION.
<<NOTE:
Evaluation.
Recommenda- tions.>> NATIONAL CLINICAL CARE COMMISSION.
(2) Additional members.--The Commission shall include additional voting members, as may be appointed by the Secretary, with expertise in the prevention, care, and epidemiology of any of the diseases and complications described in subsection (a), including one or more such members from each of the following categories:
(2) Additional members.--The Commission shall include additional voting members, as may be appointed by the Secretary, with expertise in the prevention, care, and epidemiology of any of the diseases and complications described in subsection [[Page 131 STAT.
1262]] (a), including one or more such members from each of the following categories:
(d) Operating Plan.--Not later than 90 days after its first meeting, the Commission shall submit to the Secretary of Health and Human Services and the Congress an operating plan for carrying out the activities of the Commission as described in subsection (c).
(d) <<NOTE:
Such operating plan may include-- (1) a list of specific activities that the Commission plans to conduct for purposes of carrying out the duties described in each of the paragraphs in subsection (c);
Deadline.>> Operating Plan.--Not later than 90 days after its first meeting, the Commission shall submit to the Secretary of Health and Human Services and the Congress an operating plan for carrying out the activities of the Commission as described in subsection (c).
Such operating plan may include-- [[Page 131 STAT.
1263]] (1) a list of specific activities that the Commission plans to conduct for purposes of carrying out the duties described in each of the paragraphs in subsection (c);
Passed the Senate September 6, 2017.
Approved November 2, 2017.
Attest:
LEGISLATIVE HISTORY--S.
Secretary.
920:
115th CONGRESS 1st Session S.
--------------------------------------------------------------------------- CONGRESSIONAL RECORD, Vol.
920 _______________________________________________________________________ AN ACT To establish a National Clinical Care Commission.
163 (2017):
Sept.
6, considered and passed Senate.
Oct.
11, considered and passed House.
<all>
View plain text versions (5)

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  3. Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.

  4. Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.

  5. Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.

  6. Placed on Senate Legislative Calendar under General Orders. Calendar No. 47.

  7. Measure laid before Senate by unanimous consent. (consideration: CR S5019-5020)

  8. Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.(text: CR S5019-5020)

  9. Passed Senate with amendments by Unanimous Consent. (text: CR S5019-5020)

  10. Message on Senate action sent to the House.

  11. Received in the House.

  12. Held at the desk.

  13. Mr. Olson moved to suspend the rules and pass the bill.

  14. Considered under suspension of the rules. (consideration: CR H7946-7948)

  15. DEBATE - The House proceeded with forty minutes of debate on S. 920.

  16. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H7946)

  17. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7946)

  18. Motion to reconsider laid on the table Agreed to without objection.

  19. Presented to President.

  20. Presented to President.

  21. Signed by President.

  22. Signed by President.

  23. Became Public Law No: 115-80.

  24. Became Public Law No: 115-80.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S 920 do?
(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.) National Clinical Care Commission Act (Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs. The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.
Who sponsors S 920?
S 920 is sponsored by Shaheen, Jeanne (Democratic).
What is the current status of S 920?
This bill has been enacted into law. Introduced April 24, 2017. Enacted.
Where can I track S 920?
Track S 920 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 920

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of S 920

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →